Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
RCP Venture Capital is an emerging venture capital fund based in Cambridge, Massachusetts. Founded to address the capital gap faced by early-stage life science companies, RCP focuses on biotechnology and medical devices. The firm partners with innovative companies to support their clinical development and commercialization efforts, aiming to enhance the success rates of startups in these sectors.
Currently, RCP Venture Capital operates with a flexible investment model that includes both a core venture fund and special purpose vehicle (SPV) structures. This approach allows them to adapt to the unique needs of their portfolio companies. Although specific quantitative metrics such as fund size and team size are not disclosed, the firm is actively engaged in the life sciences sector, particularly in therapeutics, diagnostics, medical devices, and health tech.
RCP Venture Capital collaborates closely with Rapid Commercialization Partners, leveraging their expertise to enhance the commercialization strategies of its portfolio companies. This partnership is crucial for navigating the complexities of clinical development and market entry.
RCP Venture Capital invests primarily in the life sciences sector, targeting areas such as therapeutics, diagnostics, medical devices, and health tech. Their investment strategy is designed to support early-stage companies, particularly those in pre-seed, seed, and Series A funding stages. The firm employs a flexible investment model that includes both a core venture fund and special purpose vehicle (SPV) structures, allowing for tailored support to meet the specific needs of each company.
In therapeutics, RCP focuses on companies developing novel drugs, biologics, and advanced therapies, especially in rare and orphan diseases, oncology, neurology, and cardiology. The diagnostics sector includes innovators creating precision diagnostics, companion tests, and advanced biomarker platforms. In the medical devices space, RCP targets companies involved in implantables, surgical tools, and combination products. Additionally, the health tech sector encompasses digital health solutions, AI-enabled platforms, and connected care technologies.
RCP Venture Capital seeks to bridge the capital gap for early-stage life science companies, particularly in biotechnology and medical devices. They look for founders with innovative ideas and a strong commitment to advancing their technologies through clinical development.
Christina J. Ansted, MPH, CCMEP - Managing Partner. Christina has extensive experience in the life sciences sector, focusing on clinical development and commercialization strategies. She holds a Master of Public Health and is a Certified Clinical Medical Educator Professional.
Michael Janes - Managing Partner. Michael brings a wealth of knowledge in venture capital and life sciences, with a strong background in supporting early-stage companies through their development phases.
What are RCP Venture Capital's investment criteria?
RCP Venture Capital focuses on early-stage life science companies, particularly in biotechnology and medical devices. They invest in sectors such as therapeutics, diagnostics, medical devices, and health tech, targeting pre-seed, seed, and Series A stages.
How can startups apply or pitch to RCP Venture Capital?
Startups interested in pitching to RCP Venture Capital should prepare a detailed presentation that outlines their business model, market opportunity, and clinical development strategy. While specific application procedures are not detailed, a direct outreach via their contact information is recommended.
What makes RCP Venture Capital different from other investors?
RCP Venture Capital distinguishes itself by focusing specifically on the capital gap in early-stage life science companies. Their collaboration with Rapid Commercialization Partners enhances the commercialization strategies of their portfolio companies, providing valuable insights and support.
What is the geographic scope of RCP Venture Capital's investments?
The firm primarily invests in companies based in the United States, particularly those located in regions with strong life sciences ecosystems.
What is RCP Venture Capital's post-investment involvement like?
RCP Venture Capital actively collaborates with its portfolio companies, leveraging the expertise of Rapid Commercialization Partners to enhance their commercialization strategies. This involvement is crucial for navigating clinical development and market entry.
What is the typical check size for investments made by RCP Venture Capital?
While specific check sizes are not disclosed, RCP Venture Capital focuses on early-stage investments, which typically range from pre-seed to Series A funding rounds.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.